MarketInOut Stock Screener Log In | Sign Up
 

Anbio Biotechnology

NASDAQ • Healthcare • Medical Instruments & Supplies • Quote as of 10/23/2026
Anbio Biotechnology stock price and volume chart

Company Profile

IndustryMedical Instruments & Supplies
SectorHealthcare
ExchangeNASDAQ
Market Capitalization167.23 mln
Float39.69 mln
Earnings Date11/13/2026

EPS

0.15
Marginal

P / E

25.40
Elevated

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

1.81
Highly suspicious

Relative Strength

14 / 100
Significantly lagging

Pre-Tax Margin

74%
Exceptional margin

Business Description

Founded in 2021 and headquartered in Frankfurt am Main, Germany, Anbio Biotechnology develops and sells medical testing products used to detect infectious diseases, including COVID-19 and influenza. The company offers a wide range of diagnostic tools suitable for home use, clinical settings, and laboratory environments. Its products are available across major global markets, including Europe, North America, Asia Pacific, South America, and Africa.

Key Fundamentals

EPS0.15
P/E25.40
ROE25.20
RPS0.20
ROIC44.23
ROA24.61
EBITDA, mln7.19
EV / EBITDA36.53
EV / EBIT36.53
Revenue, mln9.74
EV / Revenue26.94

Quote Details

Last 3.81
Change 0.1 (2.7%)
Open 3.71
Volume 25,841
Turnover 98,454
Average Volume 55,095

Financial Ratios

Pre-Tax Profit Margin74
Leverage Ratio1.00
Current Ratio344
Price / Book7.78
Price / Tangible Book7.78
Price / Free Cash Flow166
Price / Sales28.37

Financial Strength

Altman Z-Score1576
Piotroski F-Score 5 / 9
Beneish M-Score1.81
Price to Graham Number3.62
Short Ratio0.23
Short % of Float0.12

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 21.73% 98 / 100   
1 Month -38.05% 8 / 100   
2 Months -59.98% 6 / 100   
6 Months -86.07% 3 / 100   
1 Year -86.3% 7 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog